Skip to main content
Log in

Posaconazole less costly in prolonged neutropenia

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. COLLINS CD, Ellis JJ, Kaul DR.Comparative cost-effectiveness of posaconazole versus fluconazole or itraconazole prophylaxis in patients with prolonged neutropenia. American Journal of Health-System Pharmacy 65: 2237-2243, No. 23, 1 Dec 2008

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Posaconazole less costly in prolonged neutropenia. Pharmacoecon. Outcomes News 570, 8 (2009). https://doi.org/10.2165/00151234-200905700-00023

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905700-00023

Keywords

Navigation